Skip to main content
Kara Margolis, MD, Pediatric Gastroenterology, New York, NY

Kara Gross Margolis MD

Pediatric Nutrition


Associate Professor of Molecular Pathobiology, Cell Biology and Pediatrics at NYU Langone, NYU and the NYU College of Dentistry Associate Director, NYU Pain Research Center

Join to View Full Profile
  • 3959 BroadwayNew York, NY 10032

  • Phone+1 212-305-5903

Dr. Margolis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Kara Margolis is the Director of the NYU Pain Research Center and an Associate Professor of Pediatrics, Molecular Pathobiology and Cell biology at New York University, the NYU College of Dentistry and the NYU Grossman School of Medicine.

    Dr. Margolis completed a pediatrics residency at the Albert Einstein College of Medicine and a pediatric gastroenterology fellowship at Harvard Medical School. Prior to joining NYU, she held a tenured position as an Associate Professor of Pediatrics at Columbia University.

    Dr. Margolis is a pediatric gastroenterologist and physician-scientist with recognized clinical and scientific expertise in disorders that affect the gut and the brain, including disorders of gut brain interactions (DGBI) and well as gastrointestinal problems in children with autism spectrum disorders.

    In the laboratory, Dr. Margolis leads clinical, translational and basic science research programs whose themes center around gut serotonin signaling mechanisms in gut-brain axis conditions. Her current major focuses are on the role on gut serotonin in mood dysfunction and related abdominal pain disorders, the effects of in utero medication exposures on the development of DGBIs and the gastrointestinal and behavioral outcomes in children with Autism after nutritional interventions.

    Kara's work has been published in journals including Gastroenterology, Gut, JCI, PNAS, Cell and Cell Stem Cell. Her work is currently funded by the NIH and the Department of Defense as several foundations and pharmaceutical companies.

Education & Training

  • Boston Children’s Hospital//Boston Medical Center
    Boston Children’s Hospital//Boston Medical CenterFellowship, Pediatric Gastroenterology, 2004 - 2007
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2001 - 2004
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2026
  • MA State Medical License
    MA State Medical License 2005 - 2008
  • Pediatric Gastroenterology
    American Board of Pediatrics Pediatric Gastroenterology

Publications & Presentations

PubMed

Press Mentions

  • Antidepressants in Pregnancy Linked to Children’s Gut Issues—What’s Known and a Potential Treatment Approach
    Antidepressants in Pregnancy Linked to Children’s Gut Issues—What’s Known and a Potential Treatment ApproachApril 4th, 2025
  • New Study Explores Safer Antidepressants for Pregnant Women
    New Study Explores Safer Antidepressants for Pregnant WomenJanuary 27th, 2025
  • SSRI Antidepressants May Cause Fewer Side Effects When Targeted to the Gut
    SSRI Antidepressants May Cause Fewer Side Effects When Targeted to the GutDecember 12th, 2024
  • Join now to see all

Grant Support

  • Differentiating the roles and underlying mechanisms of serotonin in the gut epithelium and ENS to create a novel drug delivery system to treat disorders of gut-brain interaction and mood dysfunctionNEW YORK UNIVERSITY2024–2029
  • A Prospective Study Examining the Role of Gestational SSRI Exposure in the Development of Functional Gastrointestinal DisordersNEW YORK UNIVERSITY2021–2025
  • Linkage of s100a10 (p11) to enteric 5-HT4-mediated serotonergic signaling roles in GI motility, enteric nervous system development, and co-morbid dysfunction of gut and brainNEW YORK UNIVERSITY2021–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: